Hu Huang to Tumor Necrosis Factor-alpha
This is a "connection" page, showing publications Hu Huang has written about Tumor Necrosis Factor-alpha.
Connection Strength
1.003
-
Saddala MS, Huang H. Identification of novel inhibitors for TNFa, TNFR1 and TNFa-TNFR1 complex using pharmacophore-based approaches. J Transl Med. 2019 Jul 02; 17(1):215.
Score: 0.565
-
Huang H, Gandhi JK, Zhong X, Wei Y, Gong J, Duh EJ, Vinores SA. TNFalpha is required for late BRB breakdown in diabetic retinopathy, and its inhibition prevents leukostasis and protects vessels and neurons from apoptosis. Invest Ophthalmol Vis Sci. 2011 Mar; 52(3):1336-44.
Score: 0.318
-
Huang H, Liu Y, Wang L, Li W. Age-related macular degeneration phenotypes are associated with increased tumor necrosis-alpha and subretinal immune cells in aged Cxcr5 knockout mice. PLoS One. 2017; 12(3):e0173716.
Score: 0.120